Management tracks: Probiodrug, Alder

Neurology company Probiodrug AG (Euronext:PBD) said Chairman and CEO Konrad Glund will retire, effective April 30. He will be succeeded by Ulrich Dauer, who was CEO of Ventaleon GmbH (Gemünden, Germany). Probiodrug also said CFO Hendrik Liebers has resigned.

Neurology and inflammation company Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) named Eric Carter interim CMO. He was SVP, CMO and global head of clinical & non-clinical development at Allergan plc (NYSE:AGN)...